Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1123)
CYPHERPUNK TECHNOLOGIES INC. (CYPH)
Martin Patricia A. — Director
Shares
50,000
Price
$3.86
Total Value
$193.00K
Shares Held After
118,750
% of Holdings
29.6%
Adagene Inc. (ADAG)
Tam Man Kin — Director
Shares
2,000
Price
$3.00
Total Value
$6.00K
Shares Held After
12,000
% of Holdings
16.7%
Pharvaris N.V. (PHVS)
Monges Viviane — Director
Shares
11,969
Price
$33.05
Total Value
$395.52K
Shares Held After
5,500
% of Holdings
68.5%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
49,036
Price
$2.69
Total Value
$131.91K
Shares Held After
1,046,003
% of Holdings
4.7%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
7,401
Price
$21.03
Total Value
$155.65K
Shares Held After
0
% of Holdings
100.0%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
5,099
Price
$20.19
Total Value
$102.97K
Shares Held After
7,401
% of Holdings
40.8%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
10,000
Price
$20.95
Total Value
$209.50K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$500.05
Total Value
$120.01K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
90
Price
$498.90
Total Value
$44.90K
Shares Held After
324,683
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
270
Price
$498.38
Total Value
$134.56K
Shares Held After
324,773
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
766
Price
$497.27
Total Value
$380.91K
Shares Held After
325,043
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
525
Price
$496.38
Total Value
$260.60K
Shares Held After
325,809
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
155
Price
$495.17
Total Value
$76.75K
Shares Held After
326,334
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$493.72
Total Value
$79.00K
Shares Held After
326,489
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$492.54
Total Value
$236.42K
Shares Held After
326,649
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
824
Price
$491.65
Total Value
$405.12K
Shares Held After
327,129
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,440
Price
$490.48
Total Value
$706.29K
Shares Held After
327,953
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,162
Price
$489.52
Total Value
$1.06M
Shares Held After
329,393
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,388
Price
$488.70
Total Value
$1.17M
Shares Held After
331,555
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
4,528
Price
$1.61
Total Value
$7.29K
Shares Held After
0
% of Holdings
100.0%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
114,851
Price
$1.61
Total Value
$184.91K
Shares Held After
0
% of Holdings
100.0%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
4,528
Price
$1.61
Total Value
$7.29K
Shares Held After
0
% of Holdings
100.0%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
114,851
Price
$1.61
Total Value
$184.91K
Shares Held After
0
% of Holdings
100.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
43
Price
$41.05
Total Value
$1.77K
Shares Held After
456,767
% of Holdings
0.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
215
Price
$39.86
Total Value
$8.57K
Shares Held After
456,810
% of Holdings
0.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
1,952
Price
$39.05
Total Value
$76.23K
Shares Held After
457,025
% of Holdings
0.4%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
30,000
Price
$99.40
Total Value
$2.98M
Shares Held After
380,209
% of Holdings
7.3%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,900
Price
$1.05
Total Value
$2.00K
Shares Held After
383,885
% of Holdings
0.5%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
5,318
Price
$2.10
Total Value
$11.17K
Shares Held After
2,855,318
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Kayyem Jon Faiz — Director
Shares
5,000
Price
$100.00
Total Value
$500.00K
Shares Held After
434,360
% of Holdings
1.2%
Mineralys Therapeutics, Inc. (MLYS)
Slingsby Brian Taylor — Director
Shares
104,320
Price
$28.81
Total Value
$3.01M
Shares Held After
7,805,718
% of Holdings
1.3%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
10,000
Price
$20.95
Total Value
$209.50K
Shares Held After
0
% of Holdings
100.0%
IMPACT BIOMEDICAL INC. (IBO)
DSS, INC. — 10% Owner
Shares
723
Price
$0.55
Total Value
$397.65
Shares Held After
589,701
% of Holdings
0.1%
CRISPR Therapeutics AG (CRSP)
KASINGER JAMES R. — General Counsel and Secretary
Shares
10,400
Price
$60.24
Total Value
$626.46K
Shares Held After
94,784
% of Holdings
9.9%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
1,088
Price
$1.65
Total Value
$1.80K
Shares Held After
4,528
% of Holdings
19.4%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
27,612
Price
$1.65
Total Value
$45.56K
Shares Held After
114,851
% of Holdings
19.4%
Revolution Medicines, Inc. (RVMD)
ANDERSON ELIZABETH M — Director
Shares
100
Price
$195.15
Total Value
$19.52K
Shares Held After
4,333
% of Holdings
2.3%
Revolution Medicines, Inc. (RVMD)
ANDERSON ELIZABETH M — Director
Shares
1,500
Price
$194.59
Total Value
$291.88K
Shares Held After
4,433
% of Holdings
25.3%
Revolution Medicines, Inc. (RVMD)
ANDERSON ELIZABETH M — Director
Shares
2,648
Price
$193.44
Total Value
$512.23K
Shares Held After
5,933
% of Holdings
30.9%
Revolution Medicines, Inc. (RVMD)
ANDERSON ELIZABETH M — Director
Shares
4,985
Price
$192.54
Total Value
$959.81K
Shares Held After
8,581
% of Holdings
36.7%
Revolution Medicines, Inc. (RVMD)
ANDERSON ELIZABETH M — Director
Shares
910
Price
$191.85
Total Value
$174.59K
Shares Held After
13,566
% of Holdings
6.3%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
1,088
Price
$1.65
Total Value
$1.80K
Shares Held After
4,528
% of Holdings
19.4%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
27,612
Price
$1.65
Total Value
$45.56K
Shares Held After
114,851
% of Holdings
19.4%
enGene Therapeutics Inc. (ENGN)
Grossman William — Director
Shares
5,102
Price
$1.97
Total Value
$10.05K
Shares Held After
5,102
% of Holdings
100.0%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP&Chairman, Partnering
Shares
3,927
Price
$58.93
Total Value
$231.40K
Shares Held After
270,401
% of Holdings
1.4%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP&Chairman, Partnering
Shares
96,073
Price
$58.51
Total Value
$5.62M
Shares Held After
274,328
% of Holdings
25.9%
Adlai Nortye Group Ltd. (ANL)
Ji Ping — Director
Shares
5,000
Price
$16.63
Total Value
$83.15K
Shares Held After
131,667
% of Holdings
3.7%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
800
Price
$36.19
Total Value
$28.95K
Shares Held After
115,167
% of Holdings
0.7%
Quantum-Si Inc (QSI)
LaPointe Christian — GC&Corp. Secretary
Shares
4,721
Price
$0.76
Total Value
$3.59K
Shares Held After
1,167,913
% of Holdings
0.4%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
2,493
Price
$0.76
Total Value
$1.90K
Shares Held After
1,716,684
% of Holdings
0.1%
Showing 201–250 of 1123 transactions (page 5 of 23)